Literature DB >> 12007965

Secondary neutron dose during proton therapy using spot scanning.

Uwe Schneider1, Stefano Agosteo, Eros Pedroni, Jürgen Besserer.   

Abstract

PURPOSE: During proton radiotherapy, secondary neutrons are produced by nuclear interactions in the material in the beam line before and after entering the patient. The dose equivalent deposited by these neutrons is usually not considered in routine treatment planning. In this study, we estimated the neutron dose in patients from a spot scanning beam line by performing measurements and Monte Carlo simulations. METHODS AND MATERIALS: Measurements of the secondary neutron dose were performed during irradiation of a water phantom with 177-MeV protons using a Bonner sphere and CR39 etch detectors. Additionally, Monte Carlo simulations were performed using the FLUKA code.
RESULTS: A comparison of our measurements with measurements taken at a beam line using the scatter foil technique shows a dose advantage of at least 10 for the spot scanning technique. In the region of the Bragg peak, the neutron dose equivalent can reach for a medium-sized target volume approximately 1% of the treatment dose. Neutron doses expected in healthy tissues of the patient (in the not-treated volume) are for large and medium target volumes, approximately 0.004 Sv and 0.002 Sv per treatment Gy, respectively.
CONCLUSIONS: We conclude from the measurements and simulations that the dose deposited by secondary neutrons during proton radiotherapy using the spot scanning technique can be neglected in the treatment region. In the healthy tissue, the dose coming from neutrons (0.002 Sv per treatment Gy) is approximately a factor of two larger than during photon treatment (0.001 Sv). These contributions to the integral dose from neutrons are still very low when compared to the dose sparing that can be achieved by using a proton beam instead of photons.

Entities:  

Mesh:

Year:  2002        PMID: 12007965     DOI: 10.1016/s0360-3016(01)02826-7

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  55 in total

1.  Nuclear collision processes around the Bragg peak in proton therapy.

Authors:  Yuka Matsuzaki; Hiroyuki Date; Kenneth Lee Sutherland; Yoshiaki Kiyanagi
Journal:  Radiol Phys Technol       Date:  2009-12-29

2.  Predicted risks of second malignant neoplasm incidence and mortality due to secondary neutrons in a girl and boy receiving proton craniospinal irradiation.

Authors:  Phillip J Taddei; Anita Mahajan; Dragan Mirkovic; Rui Zhang; Annelise Giebeler; David Kornguth; Mark Harvey; Shiao Woo; Wayne D Newhauser
Journal:  Phys Med Biol       Date:  2010-11-12       Impact factor: 3.609

3.  Assessment of out-of-field absorbed dose and equivalent dose in proton fields.

Authors:  Ben Clasie; Andrew Wroe; Hanne Kooy; Nicolas Depauw; Jay Flanz; Harald Paganetti; Anatoly Rosenfeld
Journal:  Med Phys       Date:  2010-01       Impact factor: 4.071

4.  Contribution to Neutron Fluence and Neutron Absorbed Dose from Double Scattering Proton Therapy System Components.

Authors:  A Pérez-Andújar; W D Newhauser; P M Deluca
Journal:  Nucl Technol       Date:  2009-01-01

5.  Clinical characterization of a proton beam continuous uniform scanning system with dose layer stacking.

Authors:  J B Farr; A E Mascia; W C Hsi; C E Allgower; F Jesseph; A N Schreuder; M Wolanski; D F Nichiporov; V Anferov
Journal:  Med Phys       Date:  2008-11       Impact factor: 4.071

6.  Monte Carlo and analytical model predictions of leakage neutron exposures from passively scattered proton therapy.

Authors:  Angélica Pérez-Andújar; Rui Zhang; Wayne Newhauser
Journal:  Med Phys       Date:  2013-12       Impact factor: 4.071

7.  Evaluation of energy deposition and secondary particle production in proton therapy of brain using a slab head phantom.

Authors:  Sayyed Bijan Jia; Mohammad Hadi Hadizadeh; Ali Asghar Mowlavi; Mahdy Ebrahimi Loushab
Journal:  Rep Pract Oncol Radiother       Date:  2014-05-01

Review 8.  Assessment of the risk for developing a second malignancy from scattered and secondary radiation in radiation therapy.

Authors:  Harald Paganetti
Journal:  Health Phys       Date:  2012-11       Impact factor: 1.316

9.  Neutron production from beam-modifying devices in a modern double scattering proton therapy beam delivery system.

Authors:  Angélica Pérez-Andújar; Wayne D Newhauser; Paul M Deluca
Journal:  Phys Med Biol       Date:  2009-01-16       Impact factor: 3.609

10.  Reduction of the secondary neutron dose in passively scattered proton radiotherapy, using an optimized pre-collimator/collimator.

Authors:  David J Brenner; Carl D Elliston; Eric J Hall; Harald Paganetti
Journal:  Phys Med Biol       Date:  2009-09-24       Impact factor: 3.609

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.